跳至主要内容
临床试验/NL-OMON48381
NL-OMON48381招募中不适用

PRegnancy Outcomes and Maternal Insulin Sensitivity - PROMIS

niversitair Medisch Centrum Groningen0 个研究点目标入组 130 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Healthy singleton pregnant women (10-12 weeks of gestation)
  • - BMI *25 kg/m2
  • - Fasting Blood Glucose (FBG *7.0 mmol/l)
  • - Dutch or English speaking
  • - Written informed consent

排除标准

  • - Serious health complications (Hypertension, Hyperlipidemia, Asthma, Haemochromatosis) or medication use that influence the glucose metabolism or fetal growth (e.g. corticosteroids).
  • - Multiple pregnancy
  • - pre-existing Diabetes type 1 and 2 defined as FBG *7.0 mmol/l or use of diabetes medication
  • - Participation in any other studies involving the investigation of medication or nutritional products or antibiotic use in the two weeks prior to entry into the study
  • - HIV/Hepatitis
  • - Expectation of non-compliance to the study protocol, among others, a fear of needles
  • - Known allergies or intolerances for nutritional ingredients in the MTT
  • - Psychological dysfunctions

研究者

相似试验